• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞静止与激活之间的 microRNA 相互作用。

MicroRNA interplay between hepatic stellate cell quiescence and activation.

机构信息

Department of Pharmacology, Biomedical Research Unit and Laboratory Animal Centre, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), No.162, PH Road, Chennai, Tamil Nadu, 600 077, India.

出版信息

Eur J Pharmacol. 2020 Oct 15;885:173507. doi: 10.1016/j.ejphar.2020.173507. Epub 2020 Aug 25.

DOI:10.1016/j.ejphar.2020.173507
PMID:32858048
Abstract

Hepatic stellate cells (HSCs) activation play a significant role in the progression of hepatic fibrosis. During chronic liver diseases, hepatocytes are damaged severely and secrete several pro-inflammatory markers and profibrogenic cytokines via modulation of a variety of signaling pathways that are responsible for the activation of HSCs. The microRNAs (miRNA or miR) have the potential to modulate fibrogenic signaling pathways in HSCs. A variety of miRNAs are identified as profibrogenic and are capable of activating HSCs by modulating fibrosis-associated signaling pathways such as transforming growth factor-β/Smad, Wnt/β-catenin, Hedgehog, Snail and Notch in the injured liver. On the other hand, HSCs also have certain antifibrotic miRNAs and these include miR-16, miR-19b, miR-29, miR-30, miR-101, miR-122, miR-133a, miR-144, miR-146a, miR-150-5p, miR-155, miR-195, miR-200a, miR-214, miR-335, miR-370, miR-454, miR-483, etc. are responsible for maintenance of the quiescent phenotype of normal HSCs, apoptosis induction and phenotypic reversion of activated HSCs, inhibition of HSCs proliferation, suppression of the extracellular matrix-associated gene expressions, etc. Thus, understanding of HSCs specific miRNAs regulation may provide new ideas for the targeted therapy of hepatic fibrosis at molecular level in the near future. Therefore, this review focusses on the modulation of miRNAs profile during the HSCs activation in the fibrotic liver.

摘要

肝星状细胞(HSCs)的激活在肝纤维化的进展中起着重要作用。在慢性肝病中,肝细胞受到严重损伤,通过调节多种信号通路分泌多种促炎标志物和促纤维化细胞因子,这些信号通路负责 HSCs 的激活。微小 RNA(miRNA 或 miR)具有调节 HSCs 纤维化信号通路的潜力。多种 miRNA 被鉴定为促纤维化,并能够通过调节纤维化相关信号通路如转化生长因子-β/Smad、Wnt/β-catenin、Hedgehog、Snail 和 Notch 在受损的肝脏中激活 HSCs。另一方面,HSCs 也具有某些抗纤维化的 miRNA,包括 miR-16、miR-19b、miR-29、miR-30、miR-101、miR-122、miR-133a、miR-144、miR-146a、miR-150-5p、miR-155、miR-195、miR-200a、miR-214、miR-335、miR-370、miR-454、miR-483 等,这些 miRNA 负责维持正常 HSCs 的静止表型、诱导激活的 HSCs 凋亡和表型逆转、抑制 HSCs 增殖、抑制细胞外基质相关基因表达等。因此,理解 HSCs 特异性 miRNA 调控可能为肝纤维化的分子靶向治疗提供新的思路。因此,本综述重点介绍了在纤维化肝脏中 HSCs 激活过程中 miRNA 谱的调节。

相似文献

1
MicroRNA interplay between hepatic stellate cell quiescence and activation.肝星状细胞静止与激活之间的 microRNA 相互作用。
Eur J Pharmacol. 2020 Oct 15;885:173507. doi: 10.1016/j.ejphar.2020.173507. Epub 2020 Aug 25.
2
MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.MicroRNA-101 通过靶向 TGFβ 信号通路抑制肝纤维化。
J Pathol. 2014 Sep;234(1):46-59. doi: 10.1002/path.4373. Epub 2014 Jun 17.
3
Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.骨桥蛋白通过 miRNA-129-5p 抑制促进肝星状细胞胶原 I 的合成。
Exp Cell Res. 2018 Jan 15;362(2):343-348. doi: 10.1016/j.yexcr.2017.11.035. Epub 2017 Dec 2.
4
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.miR-19b 对肝星状细胞介导的肝纤维化形成的抑制作用。
Hepatology. 2012 Jul;56(1):300-10. doi: 10.1002/hep.25613. Epub 2012 Jun 18.
5
Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.miR-200a 在 TGF-β1 介导的肝星状细胞活化中的作用。
Mol Cell Biochem. 2014 Mar;388(1-2):11-23. doi: 10.1007/s11010-013-1895-0. Epub 2013 Nov 16.
6
Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.miR-33a 通过激活 Akt 在肝星状细胞中发挥促纤维化作用。
Cell Signal. 2014 Jan;26(1):141-8. doi: 10.1016/j.cellsig.2013.09.018. Epub 2013 Oct 4.
7
The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl-induced hepatic fibrosis in mice.miR-139-5p/外周髓鞘蛋白 22 轴调控 TGF-β诱导的肝星状细胞活化和 CCl 诱导的肝纤维化在小鼠中。
Life Sci. 2021 Jul 1;276:119294. doi: 10.1016/j.lfs.2021.119294. Epub 2021 Mar 3.
8
Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p.通过细胞或外泌体微小RNA-199a-5p靶向结缔组织生长因子(CCN2),肝星状细胞中的纤维化信号传导受到抑制。
Am J Pathol. 2016 Nov;186(11):2921-2933. doi: 10.1016/j.ajpath.2016.07.011. Epub 2016 Sep 21.
9
MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.微小RNA-9通过直接靶向多药耐药相关蛋白1/ABCC1抑制肝星状细胞的激活和增殖,从而限制肝纤维化。
Oncol Rep. 2017 Mar;37(3):1698-1706. doi: 10.3892/or.2017.5382. Epub 2017 Jan 17.
10
MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.microRNA-214 通过抑制 Sufu 表达促进肝星状细胞活化和肝纤维化。
Cell Death Dis. 2018 Jun 18;9(7):718. doi: 10.1038/s41419-018-0752-1.

引用本文的文献

1
Overexpression miR-125a-5p inhibits HSCs activation and alleviates liver fibrosis through TGF-β/Smad2/3 signaling pathway and autophagy.miR-125a-5p过表达通过TGF-β/Smad2/3信号通路和自噬抑制肝星状细胞激活并减轻肝纤维化。
Cell Death Discov. 2025 Sep 1;11(1):419. doi: 10.1038/s41420-025-02694-4.
2
Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study.慢性丙型肝炎病毒感染患者中,细胞外囊泡衍生的微小RNA作为肝纤维化的非侵入性标志物:一项初步研究。
Noncoding RNA Res. 2025 Mar 5;12:132-140. doi: 10.1016/j.ncrna.2025.03.004. eCollection 2025 Jun.
3
miR-372-3p represses hepatic stellate cell activation via the RhoC/ROCK pathway.
微小RNA-372-3p通过RhoC/ROCK信号通路抑制肝星状细胞活化。
Cytotechnology. 2025 Apr;77(2):60. doi: 10.1007/s10616-025-00715-9. Epub 2025 Feb 14.
4
Application of mesenchymal stem cells in liver fibrosis and regeneration.间充质干细胞在肝纤维化和肝再生中的应用。
Liver Res. 2024 Nov 26;8(4):246-258. doi: 10.1016/j.livres.2024.11.004. eCollection 2024 Dec.
5
Bone marrow mesenchymal stem cell-originated exosomes suppress activation of hepatic stellate cells through the miR-144-3p/SLC7A11 axis.骨髓间充质干细胞来源的外泌体通过miR-144-3p/SLC7A11轴抑制肝星状细胞的激活。
Clin Exp Hepatol. 2024 Sep;10(3):197-210. doi: 10.5114/ceh.2024.142898. Epub 2024 Sep 30.
6
Extracellular Vesicles in Viral Liver Diseases.细胞外囊泡在病毒性肝病中的作用。
Viruses. 2024 Nov 17;16(11):1785. doi: 10.3390/v16111785.
7
Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review).miR-22在肝脏病变中作用机制的研究进展(综述)
Oncol Lett. 2024 Sep 6;28(5):541. doi: 10.3892/ol.2024.14674. eCollection 2024 Nov.
8
Fibrosis-Related microRNAs in Crohn's Disease with Fibrostenosis and Inflammatory Stenosis.克罗恩病纤维化相关 microRNAs 与纤维狭窄和炎症性狭窄。
Int J Mol Sci. 2024 Aug 13;25(16):8826. doi: 10.3390/ijms25168826.
9
miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD).微小RNA-221:慢性乙型肝炎病毒(HBV)和非酒精性脂肪性肝病(NAFLD)所致慢性肝病(CLD)中进行性肝损伤的潜在生物标志物。
Int J Hepatol. 2024 Aug 16;2024:4221368. doi: 10.1155/2024/4221368. eCollection 2024.
10
Serum miR‑29 is increased in mice with early liver fibrosis.早期肝纤维化小鼠血清中的miR-29水平升高。
Exp Ther Med. 2024 May 15;28(1):285. doi: 10.3892/etm.2024.12573. eCollection 2024 Jul.